• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性远端输尿管切除术治疗后进展的分析及挽救性根治性肾输尿管切除术对远端输尿管尿路上皮癌患者的影响。

Analysis of progression after elective distal ureterectomy and effects of salvage radical nephroureterectomy in patients with distal ureteral urothelial carcinoma.

机构信息

Department of Urology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Gyeonggi-do, Republic of Korea.

Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

出版信息

Sci Rep. 2024 Feb 12;14(1):3497. doi: 10.1038/s41598-024-54232-4.

DOI:10.1038/s41598-024-54232-4
PMID:38347103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10861547/
Abstract

We compared the progression patterns after radical nephroureterectomy (RNU) and elective distal ureterectomy (DU) in patients with urothelial carcinoma of the distal ureter. Between Jan 2011 and Dec 2020, 127 patients who underwent RNU and 46 who underwent elective DU for distal ureteral cancer were enrolled in this study. The patterns of progression and upper tract recurrence were compared between the two groups. Progression was defined as a local recurrence and/or distant metastasis after surgery. Upper tract recurrence and subsequent treatment in patients with DU were analyzed. Progression occurred in 35 (27.6%) and 10 (21.7%) patients in the RNU and DU groups, respectively. The progression pattern was not significantly different (p = 0.441), and the most common progression site was the lymph nodes in both groups. Multivariate logistic regression analysis revealed that pT2 stage, concomitant lymphovascular invasion, and nodal stage were significant predictors of disease progression. Upper tract recurrence was observed in nine (19.6%) patients with DU, and six (66.7%) patients had a prior history of bladder tumor. All patients with upper tract recurrence after DU were managed with salvage RNU. Elective DU with or without salvage treatment was not a risk factor for disease progression (p = 0.736), overall survival (p = 0.457), cancer-specific survival (p = 0.169), or intravesical recurrence-free survival (p = 0.921). In terms of progression patterns and oncological outcomes, there was no difference between patients who underwent RNU and elective DU with/without salvage treatment. Elective DU should be considered as a therapeutic option for distal ureter tumor.

摘要

我们比较了根治性肾输尿管切除术(RNU)和选择性远端输尿管切除术(DU)治疗输尿管下段尿路上皮癌患者的进展模式。2011 年 1 月至 2020 年 12 月,我们共纳入了 127 例行 RNU 和 46 例行选择性 DU 治疗输尿管下段癌的患者。比较了两组患者的进展模式和上尿路复发情况。进展定义为手术后局部复发和/或远处转移。分析了 DU 患者的上尿路复发和后续治疗情况。RNU 和 DU 组分别有 35(27.6%)例和 10(21.7%)例患者发生进展。两组的进展模式无显著差异(p=0.441),且最常见的进展部位均为淋巴结。多因素 logistic 回归分析显示,T2 期、合并脉管侵犯和淋巴结分期是疾病进展的显著预测因素。9 例(19.6%)DU 患者出现上尿路复发,6 例(66.7%)患者有膀胱肿瘤病史。所有 DU 后上尿路复发患者均行挽救性 RNU 治疗。选择性 DU 联合或不联合挽救治疗不是疾病进展(p=0.736)、总生存(p=0.457)、癌症特异性生存(p=0.169)或膀胱内无复发生存(p=0.921)的危险因素。就进展模式和肿瘤学结局而言,行 RNU 与选择性 DU 联合或不联合挽救治疗的患者之间无差异。选择性 DU 可作为治疗输尿管下段肿瘤的一种治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb5/10861547/4cdc03494ce5/41598_2024_54232_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb5/10861547/1e77ff9ead9a/41598_2024_54232_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb5/10861547/4cdc03494ce5/41598_2024_54232_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb5/10861547/1e77ff9ead9a/41598_2024_54232_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb5/10861547/4cdc03494ce5/41598_2024_54232_Fig2_HTML.jpg

相似文献

1
Analysis of progression after elective distal ureterectomy and effects of salvage radical nephroureterectomy in patients with distal ureteral urothelial carcinoma.选择性远端输尿管切除术治疗后进展的分析及挽救性根治性肾输尿管切除术对远端输尿管尿路上皮癌患者的影响。
Sci Rep. 2024 Feb 12;14(1):3497. doi: 10.1038/s41598-024-54232-4.
2
Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.比较上尿路尿路上皮癌行节段性输尿管切除术与根治性肾输尿管切除术的肿瘤学结局:一项来自法国大型多中心研究的结果。
BJU Int. 2012 Oct;110(8):1134-41. doi: 10.1111/j.1464-410X.2012.10960.x. Epub 2012 Mar 6.
3
Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter.远端输尿管切除术是治疗远端输尿管尿路上皮癌患者的一种安全的手术选择。
Urol Oncol. 2014 Jan;32(1):34.e1-8. doi: 10.1016/j.urolonc.2013.01.001. Epub 2013 Mar 15.
4
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter.保留肾单位手术与根治性肾输尿管切除术治疗远端输尿管临床器官局限性上尿路尿路上皮癌的肿瘤学结局
J Urol. 2016 May;195(5):1354-1361. doi: 10.1016/j.juro.2015.11.036. Epub 2015 Nov 21.
5
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.根治性肾输尿管切除术治疗上尿路上皮癌时远端输尿管处理对肿瘤学结果的影响。
Eur Urol. 2014 Jan;65(1):210-7. doi: 10.1016/j.eururo.2012.04.052. Epub 2012 May 4.
6
Segmental ureterectomy is not inferior to radical nephroureterectomy for either middle or distal ureter urothelial cell carcinomas within 3.5 cm.对于长度在3.5厘米以内的中段或远端输尿管尿路上皮癌,节段性输尿管切除术并不逊色于根治性肾输尿管切除术。
Int Urol Nephrol. 2017 Jul;49(7):1177-1182. doi: 10.1007/s11255-017-1576-0. Epub 2017 Mar 25.
7
Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter study.远端输尿管尿路上皮癌患者行远端输尿管切除术后与肾输尿管切除术相比,具有等效的生存率和更好的肾功能保留:一项倾向评分匹配的多中心研究。
Int J Urol. 2014 Nov;21(11):1098-104. doi: 10.1111/iju.12554. Epub 2014 Jul 14.
8
Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.完全去除膀胱袖套对根治性肾输尿管切除术治疗上尿路尿路上皮癌的肿瘤学结局的影响。
Cancer Res Treat. 2021 Jul;53(3):795-802. doi: 10.4143/crt.2020.919. Epub 2020 Dec 28.
9
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.根治性肾输尿管切除术(RNU)后膀胱内复发的预测:临床决策工具的开发。
Eur Urol. 2014 Mar;65(3):650-8. doi: 10.1016/j.eururo.2013.09.003. Epub 2013 Sep 19.
10
Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的危险因素:一项荟萃分析。
Urol Oncol. 2014 Oct;32(7):989-1002. doi: 10.1016/j.urolonc.2014.01.022. Epub 2014 Jul 28.

引用本文的文献

1
Kidney sparing surgery versus radical nephroureterectomy in upper tract urothelial carcinoma: a meta-analysis and systematic review.上尿路尿路上皮癌保留肾手术与根治性肾输尿管切除术的Meta分析和系统评价
Front Oncol. 2025 Apr 2;15:1448079. doi: 10.3389/fonc.2025.1448079. eCollection 2025.

本文引用的文献

1
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2023 年更新版。
Eur Urol. 2023 Jul;84(1):49-64. doi: 10.1016/j.eururo.2023.03.013. Epub 2023 Mar 24.
2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee.高危尿路上皮癌远端输尿管切除术的肿瘤学结局:法国膀胱癌委员会的一项多中心研究
Cancers (Basel). 2022 Nov 6;14(21):5452. doi: 10.3390/cancers14215452.
4
Robotic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma: A Trend Analysis of Utilization and a Comparative Study.机器人辅助根治性肾输尿管切除术联合膀胱袖状切除术治疗上尿路尿路上皮癌:应用趋势分析及对比研究
Cancers (Basel). 2022 May 19;14(10):2497. doi: 10.3390/cancers14102497.
5
Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma.根治性肾输尿管切除术与节段性输尿管切除术治疗上尿路上皮癌的肿瘤学和功能结局比较。
Sci Rep. 2021 Apr 9;11(1):7828. doi: 10.1038/s41598-021-87573-5.
6
Techniques and Outcomes of Robot-assisted Nephro-ureterectomy for Upper Tract Urothelial Carcinoma.机器人辅助肾输尿管切除术治疗上尿路尿路上皮癌的技术和结果。
Eur Urol Focus. 2018 Sep;4(5):657-661. doi: 10.1016/j.euf.2018.08.007. Epub 2018 Aug 23.
7
Segmental ureterectomy is not inferior to radical nephroureterectomy for either middle or distal ureter urothelial cell carcinomas within 3.5 cm.对于长度在3.5厘米以内的中段或远端输尿管尿路上皮癌,节段性输尿管切除术并不逊色于根治性肾输尿管切除术。
Int Urol Nephrol. 2017 Jul;49(7):1177-1182. doi: 10.1007/s11255-017-1576-0. Epub 2017 Mar 25.
8
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter.保留肾单位手术与根治性肾输尿管切除术治疗远端输尿管临床器官局限性上尿路尿路上皮癌的肿瘤学结局
J Urol. 2016 May;195(5):1354-1361. doi: 10.1016/j.juro.2015.11.036. Epub 2015 Nov 21.
9
Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter study.远端输尿管尿路上皮癌患者行远端输尿管切除术后与肾输尿管切除术相比,具有等效的生存率和更好的肾功能保留:一项倾向评分匹配的多中心研究。
Int J Urol. 2014 Nov;21(11):1098-104. doi: 10.1111/iju.12554. Epub 2014 Jul 14.
10
Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.原发性上尿路尿路上皮癌患者根治性肾输尿管切除术后膀胱内复发治疗后膀胱结局的独立预测因素。
Ann Surg Oncol. 2014 Sep;21(9):3151-8. doi: 10.1245/s10434-014-3657-y. Epub 2014 Mar 29.